Skip to main content
. 2017 Jul 7;14(7):e1002344. doi: 10.1371/journal.pmed.1002344

Fig 1. The percentage (%) of isolates with decreased susceptibility or resistance to extended-spectrum cephalosporin (ESC) (cefixime and/or ceftriaxone) according to the most recent World Health Organization (WHO) Gonococcal Antimicrobial Surveillance Programme (GASP) data (2014 for most countries, but for a few countries, only 2011–2013 data were available).

Fig 1

Note: The areas in grey are disputed territories (e.g., Western Sahara, Jammu, and Kashmir), and no antimicrobial resistance (AMR) data are available from these regions.